Our results also indicate that targeting miR-21 and HIF-1α with phytochemicals such as nimbolide may be a robust therapeutic approach to modulate multiple proteins and pathways deregulated in oral cancer. The gene discussed is HIF1A; the disease is lip and oral cavity carcinoma.